SESSION 2: Multiple Myeloma
Tracks
Main Session Hall
| Friday, May 16, 2025 |
| 12:15 PM - 1:35 PM |
Speaker
Dr. Afraa Mustafa
Senior Consultant Hematologist
NCCCR- Hamad Medical Corporation
Management of Myeloma. Local data and future perspectives
12:15 PM - 12:30 PM
Dr. Deena Medawi
Hematology/BMT consultant
NCCCR- Hamad Medical Corporation
The dilemma of penta-refractory myeloma patients. The role of bispecific
12:30 PM - 12:45 PM
Dr. Anas Hamad
Director of Pharmacy
Hamad Medical Corporation
Health Economics Insights in the Management of Myeloma
12:45 PM - 1:05 PM
Dr. Dina Soliman Sameh
Consultant Hematopathologist
Hamad Medical Corporation
Double Trouble: Plasma Cell Neoplasms and Secondary Hematologic Malignancies
1:05 PM - 1:20 PM
Dr. Samah Aly Kohla
Hematologist
NCCCR
Atypical Presentations of Myeloma: Clinical, Morphologic, and Immunophenotypic Variations
1:20 PM - 1:35 PMSession Chair
Honar Cherif
Chairman of Dep. of Hematology
National Center for Cancer Care & Research, Hamad Medical Corporation
